[HER2 testing in breast cancer: rereading the ASCO/CAP guideline]. | Zhonghua Wai Ke Za Zhi;51(10): 875-8, 2013 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

[HER2 testing in breast cancer: rereading the ASCO/CAP guideline].

Wang, Wei; Xiang, Jing-jing; Cui, Hai-dong; Liu, Jian; Xu, Ru-jun.

Affiliation

Xu RJ; Email:Xu_RJ@hotmail.com.

Zhonghua Wai Ke Za Zhi ; 51(10): 875-8, 2013 Oct.

Article in Zh | MEDLINE | ID: mdl-24433762

Subject(s)

Breast Neoplasms/diagnosis; Receptor, ErbB-2/analysis; Breast Neoplasms/therapy; Early Detection of Cancer; Female; Humans; Practice Guidelines as Topic

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 Type of study: Diagnostic_studies / Guideline / Screening_studies Limits: Female / Humans Language: Zh Journal: Zhonghua Wai Ke Za Zhi Year: 2013 Document type: Article Country of publication: China

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 Type of study: Diagnostic_studies / Guideline / Screening_studies Limits: Female / Humans Language: Zh Journal: Zhonghua Wai Ke Za Zhi Year: 2013 Document type: Article Country of publication: China